Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

A blood pressure drug, diltiazem, may also help treat influenza.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

AVT is highly conserved and may have antimicrobial properties.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Some gonadal hormone drugs can block filovirus entry into cells.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.